Profile
ABIO VRTX ALNY REGN ARGX SGEN
Company Name ARCA biopharma, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $34.82M $100.41B $59.77B $58.74B $48.87B $43.15B
Employees 0.00K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Thomas A. Keuer Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABIO VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
ABIO VRTX ALNY REGN ARGX SGEN
Last Close $28.8 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $28.8 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $28.8 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High 0 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 0 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
ABIO VRTX ALNY REGN ARGX SGEN
1 Month Return 0 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 0 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 0 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 0 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 0 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return 0 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABIO VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -413.94 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
ABIO VRTX ALNY REGN ARGX SGEN
Asset Growth -12.12 % -0.87 %
Gross Profit Growth 2.63 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth 27.48 % -93.69 %
Net Income Growth 46.21 % -114.8 %
Net Income 3 Yeari Growth Per Share 82.09 % -122.89 %
Net Income 5 Yeari Growth Per Share 96.41 % -145.38 %
Net Income 10 Yeari Growth Per Share 99.63 % 33.84 %
Operating Income Growth 32.64 % -106.08 %
Operating Cash Flow Growth (CFG) 54.05 % -113.93 %
Operating 3 Year CFG 78.79 % -118.65 %
Operating 5 Year CFG 96.75 % -131.3 %
Operating 10 Year CFG 99.55 % 12.43 %
EPS Growth 46.38 % -114.8 %
EPS Diluted Growth 46.38 % -114.97 %
Book Value Per Share -11.2 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -74 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -67.24 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -98.87 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -27.14 % 116.42 %
Free Cash Flow Growth 54.06 % -124.1 %
Updated On 31 Dec 2023 31 Dec 2024
Profitability
ABIO VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -27.97 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -27.91 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -32.81 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 88.25 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -4199.87 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.01 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.31 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -2.32 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 777.6 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.24 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -4199.87 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -7.12 28.69 -1147.52 15.28 122.57 -81.26
Price To Operating Cash Flows Ratio TTM -8.05 26.14 -3805.41 12.49 140 -93.1
Price Cash Flow Ratio TTM -8.05 26.14 -3805.41 12.49 140 -93.1
Income Statement (TTM)
ABIO VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.37 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABIO VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.04B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.04B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABIO VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 37
AARD Aardvark Therapeutics, Inc. Common Stock 17.1151
ABCL AbCellera Biologics Inc. 5.9236
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.62
ABOS Acumen Pharmaceuticals, Inc. 2.27
ABPWW 0.0255
ABSI Absci Corporation 4.03
ABUS Arbutus Biopharma Corporation 4.2201
ABVC ABVC BioPharma, Inc. 3.2758
ABVX Abivax SA American Depositary Shares 90.96
ACAD ACADIA Pharmaceuticals Inc. 20.885
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.325
ACIU AC Immune SA 3.67
ACLX Arcellx, Inc. 87.68
ETFs With Exposure to ABIO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 330.87
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.9
VXF Vanguard Extended Market Index Fund 0 212.02
IWC iShares Micro-Cap ETF 0.00857 154.475
DFAT Dimensional U.S. Targeted Value ETF 0.00015047 57.895
VTSAX Vanguard Total Stock Market Index Fund 0 161.49
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 161.41
VITSX Vanguard Total Stock Market Index Fund 0 161.52
DFSU Dimensional US Sustainability Core 1 ETF 0.00000116 42.605
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000237478 16.36
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 161.42
SOLR SmartETFs Sustainable Energy II ETF 2.24 31.345
DCOR Dimensional ETF Trust 0.00000603 72.19
VEMPX Vanguard Extended Market Index InstlPlus 0 398.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 302.98
Unlock